TNFRSF1A and cancer: Further molecular analysis has also distinguished EOCRC from older patients, with an absence of BRAF mutations, methylator phenotypes, and implications of Wnt/beta catenin, MAP kinase, growth factor signaling, and tumor necrosis factor receptor 1 (TNFR1) pathways being highly prominent in younger cancer patients [18].